StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.22−0.14 (-1.90%)

Close on Nov 17, 2026Market cap $631.73MP/E –Yield –

Olema Oncology pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Olema Oncology

Olema Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Olema Oncology figures

See a number that looks wrong?